titanium has been researched along with am 630 in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Geng, D; Wang, J; Wang, X; Xu, Y; Yang, H; Zhu, G; Zhu, X | 1 |
| Geng, DC; Wang, XB; Xu, YZ; Yang, HL; Zhu, GM; Zhu, XS | 1 |
| Geng, D; Mao, H; Xu, Y; Yang, H; Zhou, F; Zhu, X | 1 |
3 other study(ies) available for titanium and am 630
| Article | Year |
|---|---|
Protection against titanium particle induced osteolysis by cannabinoid receptor 2 selective antagonist.
Topics: Animals; Female; Humans; Indoles; Mice; Mice, Inbred BALB C; Osteoclasts; Osteolysis; Particle Size; Prosthesis Failure; RANK Ligand; Receptor, Cannabinoid, CB2; Skull; Titanium | 2010 |
Inhibition of titanium particle-induced inflammatory osteolysis through inactivation of cannabinoid receptor 2 by AM630.
Topics: Animals; Cell Survival; Cells, Cultured; Cytokines; Gene Expression Regulation; Indoles; Inflammation; Inflammation Mediators; Mice; Microscopy, Electron, Scanning; Osteoclasts; Osteogenesis; Osteolysis; Receptor, Cannabinoid, CB2; Titanium | 2010 |
Effects of a cannabinoid receptor 2 selective antagonist on the inflammatory reaction to titanium particles in vivo and in vitro.
Topics: Animals; Bone and Bones; Cell Line; Female; Gene Expression Regulation; Implants, Experimental; Indoles; Inflammation; Interleukin-1beta; Mice; Mice, Inbred BALB C; Particulate Matter; Receptor, Cannabinoid, CB2; RNA, Messenger; Titanium; Tumor Necrosis Factor-alpha | 2010 |